JPRN-UMIN000024703未知未知
Examination of additive effects of dulaglutide and empagliflozin to type 2 diabetic patients with poor glycemic control despite insulin administration. - Examination of additive effects of dulaglutide and empagliflozin to type 2 diabetic patients with poor glycemic control despite insulin administration.
Social medical corporations Aijinkai Chibune hospital0 个研究点目标入组 50 人开始时间: 2016年11月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with 75 years old and over,category 2,3. Patients who have not taken medicine for 3 months and over. Patients with impaired liver or kidney functions,who need adjustment of medicine.Patients with collagen disease or cancer.Patients who have economic reasons,and judged not to be appropriate by doctors.
研究者
相似试验
已完成
不适用
Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000019031Haga Diabetes Clinic40
已完成
不适用
Efficacy and safety of dulaglutide when used instead of sitagliptin in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000023245Iwasaki Naika Clinic40
招募中
不适用
Comparison of efficacy of liraglutide and dulaglutide in type 2 diabetes mellitus patientsJPRN-UMIN000019070Haga Diabetes Clinic75
已完成
不适用
Effect of dulaglutide versus liraglutide on glucose variability and oxidative stress and endothelial function in type 2 diabetes patientsType 2 diabetes mellitusJPRN-UMIN000034353Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine50
招募中
不适用
Efficacy and safety of dulaglutide in the treatment of type 2 diabetesType 2 diabetes mellitus patientsJPRN-UMIN000027255Department of nephrology, Matsunami general hospital30